These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
144 related items for PubMed ID: 10687202
21. Differences in lipoprotein (a) and apolipoprotein (a) levels in men and women with advanced coronary atherosclerosis. Stiel GM, Reblin T, Bührlen M, Lattermann A, Nienaber CA. Coron Artery Dis; 1995 Apr; 6(4):347-50. PubMed ID: 7655720 [Abstract] [Full Text] [Related]
22. Lipoprotein(a) levels and apolipoprotein(a) isoforms related to life style risk factors. Ishikawa S, Deguchi T, Hara K, Takuma S, Kayaba K, Tsutsumi A, Kario K, Igarashi M. J Epidemiol; 1999 Feb; 9(1):32-9. PubMed ID: 10098351 [Abstract] [Full Text] [Related]
24. Relationship between apolipoprotein(a) size polymorphism and coronary heart disease in overweight subjects. Emanuele E, Peros E, Minoretti P, Falcone C, D'Angelo A, Montagna L, Geroldi D. BMC Cardiovasc Disord; 2003 Dec 12; 3():12. PubMed ID: 14670093 [Abstract] [Full Text] [Related]
25. Relationship between plasma lipoprotein (a), apolipoprotein (a) phenotypes, and other coronary heart disease risk factors in a Melbourne South Asian population. Xiong ZW, Wahlqvist ML, Ibiebele TI, Biegler BM, Balazs ND, Xiong DW, Lim YL. Clin Biochem; 2004 Apr 12; 37(4):305-11. PubMed ID: 15003733 [Abstract] [Full Text] [Related]
26. Association between lipoprotein(a) levels, apo(a) isoforms and family history of premature CAD in young Asian Indians. Gambhir JK, Kaur H, Prabhu KM, Morrisett JD, Gambhir DS. Clin Biochem; 2008 May 12; 41(7-8):453-8. PubMed ID: 18280807 [Abstract] [Full Text] [Related]
27. [Phenotypic expression of Lp(a) in Spanish children and adolescents]. Gómez Gerique JA, López Martínez D, Cancelas P, Montoya MT, Gutiérrez MD, Porres A. Med Clin (Barc); 2000 Jan 15; 114(1):13-5. PubMed ID: 10782454 [Abstract] [Full Text] [Related]
33. Association of lipoprotein(a) levels and apolipoprotein(a) phenotypes with coronary heart disease in patients with essential hypertension. Gazzaruso C, Buscaglia P, Garzaniti A, Falcone C, Mariotti S, Savino S, Bonetti G, Finardi G, Geroldi D. J Hypertens; 1997 Mar 07; 15(3):227-35. PubMed ID: 9468449 [Abstract] [Full Text] [Related]
34. Genetics and cardiovascular risk: a role for apolipoprotein(a) polymorphism. Gazzaruso C, Garzaniti A, Geroldi D, Finardi G. Cardiologia; 1999 Apr 07; 44(4):347-54. PubMed ID: 10371786 [Abstract] [Full Text] [Related]
35. Assessment of asymptomatic coronary artery disease in apparently uncomplicated type 2 diabetic patients: a role for lipoprotein(a) and apolipoprotein(a) polymorphism. Gazzaruso C, Garzaniti A, Giordanetti S, Falcone C, De Amici E, Geroldi D, Fratino P. Diabetes Care; 2002 Aug 07; 25(8):1418-24. PubMed ID: 12145244 [Abstract] [Full Text] [Related]
36. Association of lipoprotein(a) concentration and apo(a) isoform size with restenosis after percutaneous transluminal coronary angioplasty. Sirikci O, Aytekin V, Demiroglu IC, Demiroglu C, Marcovina SM. Int J Clin Lab Res; 2000 Aug 07; 30(2):93-9. PubMed ID: 11043503 [Abstract] [Full Text] [Related]
38. Apolipoprotein(a) phenotypes and lipoprotein(a) concentrations in patients with renal failure. Milionis HJ, Elisaf MS, Tselepis A, Bairaktari E, Karabina SA, Siamopoulos KC. Am J Kidney Dis; 1999 Jun 07; 33(6):1100-6. PubMed ID: 10352198 [Abstract] [Full Text] [Related]
39. Lipoprotein (a) in young individuals as a marker of the presence of ischemic heart disease and the severity of coronary lesions. Zorio E, Falco C, Arnau MA, España F, Osa A, Ramon LA, Castello R, Almenar L, Palencia MA, Estelles A. Haematologica; 2006 Apr 07; 91(4):562-5. PubMed ID: 16585023 [Abstract] [Full Text] [Related]